Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
FRIDAY, Jan. 24, 2025 (HealthDay News) — Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer
Talquetamab Plus Teclistamab Shows Promise in Multiple Myeloma
THURSDAY, Jan. 9, 2025 (HealthDay News) — For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high perc
Could MRI Spot 'Pre-Cancer' Lesions of the Pancreas?
TUESDAY, Dec. 17, 2024 (HeathDay News) — Pancreatic cancer can be a silent killer — the organ is located deep inside the body, making cancer harder to detect
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab
Mediterranean Diet May Modestly Reduce Risk for Obesity-Related Cancers
Inmaculada Aguilera-Buenosvinos, Ph.D., from the University of Navarra in Spain, and colleagues examined the association between adherence to the MedDiet and the risk for ORCs. The analysis included data from 450,111 participants (mean age, 51.1 years) in the European Prospective Investigation Into Cancer and Nutrition study.
